Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Mervat M. Mattar"'
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 41, Iss 1, Pp 17-24 (2019)
Background: Acute myeloid leukemia (AML) is a potentially fatal hematological disease. Along with disease-related factors, patient-related factors, in particular age, are a strong predictor of outcome that influence treatment decisions. Many acute my
Externí odkaz:
https://doaj.org/article/30618f3836324a5e971af15cef101ca8
Autor:
Neemat M. Kassem, Alya M. Ayad, Noha M. El Husseiny, Doaa M. El-Demerdash, Hebatallah A. Kassem, Mervat M. Mattar
Publikováno v:
Journal of Global Oncology, Vol 4, Pp 1-6 (2017)
Purpose: Granulocyte-macrophage colony-stimulating factor (GM-CSF) cytokine stimulates growth, differentiation, and function of myeloid progenitors. We aimed to study the role of GM-CSF gene expression, its protein, and antibodies in patients with ac
Externí odkaz:
https://doaj.org/article/db5e77864c384866beb0b1bde2a3fb5c
Publikováno v:
Acta Medica Iranica, Vol 56, Iss 7 (2018)
Hepatitis C virus (HCV) infection is a major public health concern in Egypt with its unique genotype. Besides liver disease, HCV is a lymphotropic virus involved in the pathogenesis of various extrahepatic diseases. A causative role of HCV in the gen
Externí odkaz:
https://doaj.org/article/595f2626d1ab4819a556ac9bf5506cbf
Publikováno v:
Acta Haematologica. 141:245-253
Background: The incidence of venous thromboembolism (VTE) in haematological malignancies varies according to the type and grade of the disease and clinical variables, and there is a need to develop a tool to predict the occurrence of VTE in cancer pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f3bd750156070c6d35e2661bd303ec3
https://doi.org/10.1159/000496914
https://doi.org/10.1159/000496914
Publikováno v:
Precision Anticoagulation Medicine ISBN: 9783030257811
Autoimmune rheumatic diseases as a group are characterized by common features such as multisystem involvement, polypharmacy, and the presence of comorbidities. Recent large epidemiological studies shed light on their role as risk factors for thromboe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f1e7d817febd3338bf5a5b1659725f3
https://doi.org/10.1007/978-3-030-25782-8_7
https://doi.org/10.1007/978-3-030-25782-8_7
Autor:
Mervat M. Mattar, Alya M. Ayad, Neemat M Kassem, Doaa M. El-Demerdash, Hebatallah A Kassem, Noha M. El Husseiny
Publikováno v:
Journal of Global Oncology, Vol 4, Pp 1-6 (2017)
Journal of Global Oncology
Journal of Global Oncology
Purpose Granulocyte-macrophage colony-stimulating factor (GM-CSF) cytokine stimulates growth, differentiation, and function of myeloid progenitors. We aimed to study the role of GM-CSF gene expression, its protein, and antibodies in patients with acu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d33af609cc54d47e9d3a53c7d5d15996
http://ascopubs.org/doi/10.1200/JGO.2017.009332
http://ascopubs.org/doi/10.1200/JGO.2017.009332
Autor:
Yasser H. ElNahass, Hend N. Elleithy, Mohamed A. Samra, Ahmed Abdulgawad, Omar A Fahmy, Hossam K. Mahmoud, Raafat Abdelfattah, Mohamed Talaat, Mona Gamil, Fatma A. ElRefaey, Heba A. Nader, Gamal M. Fathy, Mohamed Abd-El-Kader, Mervat M. Mattar, Wafaa H ElMetnawy, Hala M. Fahmy
Publikováno v:
Leukemia & Lymphoma. 59:844-854
JAK2, CALR, MPL and triple-negative mutational status has a direct impact on symptom severity and disease burden assessed by MPN10 score in myeloproliferative neoplasms (MPNs). Among 93 patients; median MPN10 score was 48 (5-76) in JAK2 mutants versu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c201cf2c9fecf4bb7f786cddc2428b6
https://doi.org/10.1080/10428194.2017.1365852
https://doi.org/10.1080/10428194.2017.1365852
Autor:
Sahar Nassef, Marwa Salah, Mervat M. Mattar, Noha M. El Husseiny, Mohamed Abdelkader Morad, Ahmed Abdul Gawad, Mohamed Roshdy El Masry
Publikováno v:
Clinical lymphoma, myelomaleukemia. 19(8)
Background Identification of janus kinase 2 (JAK2) mutation even in absence of myeloproliferative disorders (MPNs) was found to be related to venous thromboembolism occurrence. Venous thrombosis screening is not routinely requested in patients with m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3b8e16a5a305f19812448ebbbeb56ae
https://pubmed.ncbi.nlm.nih.gov/32067955
https://pubmed.ncbi.nlm.nih.gov/32067955
Autor:
Noha M. El Husseiny, Noha H. Ali, Mervat M. Mattar, Doaa M. El Demerdash, Mohammed Abdel Kader Morad
Publikováno v:
Annals of Hematology. 95:1611-1616
Myeloproliferative neoplasms are characterized by a common stem cell-derived clonal proliferation, but are phenotypically diverse. JAK2 is mutated (V617F) in more than 90 % of patients with polycythemia vera (PV) and approximately 60 % of patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c3d2b7164809af6be33fad1617eeb99
https://doi.org/10.1007/s00277-016-2765-0
https://doi.org/10.1007/s00277-016-2765-0
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:S246
Objectives To describe the management and costs associated with G-CSF therapy in hematological cancer patients in multiple institutes in Egypt. Methods This study analyzed a random population sample from the Egyptian national healthcare database, foc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5bf9eb69073b15d7777213f4e798e60
https://doi.org/10.1016/s2152-2650(20)30836-3
https://doi.org/10.1016/s2152-2650(20)30836-3